Related Experiment Video
Updated: Jul 12, 2026

Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
Stopping ras in its tracks
Channing J Der1, Terry Van Dyke
1Department of Pharmacology, University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA. cjder@med.unc.edu
Abstract:
Ras interacts with many downstream effectors that regulate complex cytoplasmic signaling networks. In this issue, Gupta et al. (2007) use mouse models of Ras-mediated tumorigenesis to show that the interaction of Ras with a single isoform of phosphatidylinositol 3-kinase (PI3K), called p110alpha (PIK3CA), is critical for tumor formation. This result will stimulate re-evaluation of pharmacological approaches to target Ras for cancer treatment.
Insights
Ras protein interaction with phosphatidylinositol 3-kinase (PI3K) p110alpha is crucial for tumor formation in mouse models. This finding impacts strategies for targeting Ras in cancer therapy.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Ras proteins are key regulators of cytoplasmic signaling networks, influencing cell growth and survival.
- Aberrant Ras signaling is implicated in various human cancers, making it a significant therapeutic target.
Discussion:
- Gupta et al. demonstrate that the interaction between Ras and a specific PI3K isoform, p110alpha (PIK3CA), is essential for Ras-mediated tumorigenesis.
- This interaction is critical for the downstream signaling events that drive tumor development.
Key Insights:
- The study identifies a specific molecular interaction (Ras-p110alpha) as a critical node in Ras-driven cancer.
- Targeting the p110alpha isoform of PI3K could be a viable strategy to inhibit Ras-driven tumor formation.
Outlook:
- These findings necessitate a re-evaluation of current pharmacological approaches aimed at inhibiting Ras signaling for cancer treatment.
- Further research into isoform-specific PI3K inhibitors may offer more precise and effective cancer therapies.
Related Concept Videos
Restarting Stalled Replication Forks
Experimental RNAi
Abnormal Proliferation
The Ras Gene
Ras is a superfamily...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...

